The company is not falling under Large Corporate Category as on 31st March 2025.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals Limited has informed BSE that it does not fall under the 'Large Corporate' category as on 31st March 2025, in line with SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018. This circular applies to companies with outstanding borrowings of ₹100 crore or more and mandates a minimum portion of incremental borrowings to be raised through public debt securities. By confirming non-applicability, the company is stating that its borrowings are below the large corporate threshold. The disclosure was filed on 30th April 2025 by the Company Secretary, Gurpreet Kaur.
This is a routine compliance filing with no material impact on shareholders. The company remains outside SEBI's Large Corporate framework, meaning it has no mandatory obligation to raise a portion of its borrowings through public debt issuances.